The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

The procedure is designed to help patients who experience frequent fainting episodes that impair their quality of life.

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut? 

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

The groups hope to standardize heart failure terminology and ensure everyone is on the same page when discussing this complex condition. 

Patel, a veteran interventional cardiologist with Duke Health, was named the group's Physician of the Year in 2023. 

Thousands of procedure kits used by cardiologists and cardiac surgeons are impacted by the new Class II recall. 

Many cardiologists are earning more in 2026 than they did in 2025. However, there is a fear that compensation and wRVUs can only climb so far in this current healthcare environment before things start to stall. 

The new recall impacts thousands of portable systems. A software update is now available that should resolve any issues. 

Researchers tracked real-world data from more than 140 patients who originally received a transcatheter heart valve from Edwards Lifesciences, Medtronic or Boston Scientific. 

MRI-detected signs of cardiac remodeling may tell clinicians a thing or two about a patient's odds of developing certain cancers. Changes in heart muscle mass, for example, were linked to an increased risk of breast cancer. 

The feds cautioned that exploitation of these vulnerabilities could allow attackers to write files, access unauthorized information, or crash client servers. 

Hospitals are not the only healthcare entities competing over a limited pool of qualified compliance officers. Payers, vendors and others are in the race too. But hospitals and health systems may have the most to lose if they let down their guard on adherence to regulatory rules.